| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0140-6736(90)90488-Q |
| P698 | PubMed publication ID | 1969993 |
| P2093 | author name string | H Wilde | |
| G M Baer | |||
| D B Fishbein | |||
| C Supich | |||
| S Chutivongse | |||
| P433 | issue | 8694 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rabies | Q39222 |
| P304 | page(s) | 896-898 | |
| P577 | publication date | 1990-04-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Postexposure prophylaxis for rabies with antiserum and intradermal vaccination | |
| P478 | volume | 335 |
| Q43772717 | A preliminary study of chemo- and cytokine responses in rabies vaccine recipients of intradermal and intramuscular regimens |
| Q36538027 | A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods |
| Q73700075 | An investigation of the intradermal route as an effective means of immunization for microparticulate vaccine delivery systems |
| Q90520682 | An overview of the immunogenicity and effectiveness of current human rabies vaccines administered by intradermal route |
| Q43584586 | Economical multi-site intradermal regimen with purified chick embryo cell vaccine (Rabipur) prevents rabies in people bitten by confirmed rabid animals |
| Q71447295 | Economical use of rabies vaccine |
| Q45361123 | Efficacy of high-dose intra-dermal hepatitis B virus vaccine in previous vaccination non-responders with chronic liver disease |
| Q60191962 | Evaluating new rabies post-exposure prophylaxis (PEP) regimens or vaccines |
| Q37660987 | Evaluation of a new five-injection, two-site,intradermal schedule for purified chick embryo cell rabies vaccine: A randomized, open-label, active-controlled trial in healthy adult volunteers in India |
| Q43557203 | Human immune response to rabies nucleocapsid and glycoprotein antigens |
| Q39374950 | Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified Vero-cell rabies vaccine (CPRV): a two-stage randomised clinical trial in the Philippines |
| Q37264939 | Intradermal vaccination for infants and children |
| Q83121434 | Intradermal vaccination of pigs against FMD with 1/10 dose results in comparable vaccine efficacy as intramuscular vaccination with a full dose |
| Q43638518 | Is injection of contaminated animal bite wounds with rabies immune globulin a safe practice? |
| Q50587357 | Neutralizing antibody response after intradermal rabies vaccination in hemodialysis patients. |
| Q67824884 | One-year study of the 2-1-1 intramuscular postexposure rabies vaccine regimen in 100 severely exposed Thai patients using rabies immune globulin and Vero cell rabies vaccine |
| Q73500324 | Progress and achievement of rabies control in Thailand |
| Q90192077 | Purified Vero Cell Rabies Vaccine (PVRV, Verorab®): A Systematic Review of Intradermal Use Between 1985 and 2019 |
| Q35714659 | Rabies and other lyssavirus diseases |
| Q64128359 | Rabies control in the Republic of the Philippines: benefits and costs of elimination |
| Q24670464 | Rabies in a nine-year-old child: The myth of the bite |
| Q39374941 | Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals |
| Q84520496 | Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults |
| Q45710468 | Superiority of varicella skin test antigen over purified varicella-zoster virus glycoproteins in monitoring booster response to Oka varicella vaccine |
| Q50770001 | The real cost of rabies post-exposure treatments. |
| Q38120923 | Trend of human rabies prophylaxis in developing countries: toward optimal rabies immunization. |
Search more.